New daily pill for pancreatic cancer shows promising trial results
A clinical trial showed a new daily pill combined with chemotherapy eliminated detectable pancreatic cancer tumours in one in 12 patients.
HEROIC BREAKING NEWS, written by our newsroom0 views
A new daily pill taken with chemotherapy has wiped out signs of advanced pancreatic cancer in one in 12 trial patients, according to The Sun. The clinical trial combined the drug daraxonrasib with standard chemotherapy. One in 12 patients had no detectable tumours a year and a half after beginning the treatment. [1]
The Sun reported that the drug combination helped more patients survive over a year compared to standard treatment options. Michelle Mitchell, chief executive of Cancer Research UK, called the development the biggest leap forward in decades for pancreatic cancer patients, noting that it could offer real hope against one of the deadliest forms of cancer. [1]
As HEROIC BREAKING NEWS reported earlier, United States health regulators approved daraxonrasib, sold under the brand name Rasonque, to treat metastatic pancreatic cancer. That approval followed a clinical trial of 500 patients which showed median overall survival nearly doubled to over 13 months. The daily pill functions by targeting multiple forms of the RAS protein to slow tumour growth. [3]
In short
- One in 12 trial patients taking daraxonrasib with chemotherapy had no detectable pancreatic cancer tumours after 1.5 years.
- The drug combination improved survival rates over a year compared to standard treatments.
- Daraxonrasib targets multiple forms of the RAS protein to slow tumour growth.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Daily pill hailed as 'closest thing to a cure' could 'wipe out' deadliest cancerThe Sun, 1d ago (the report this story comes from)
Background
- [2]Adolescence (TV series) on Wikipedia
- [3]FDA approves new drug daraxonrasib for advanced pancreatic cancer HEROIC BREAKING NEWS, 28d ago
Our newsroom writes these reports with the help of software, from the 3 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from HEROIC BREAKING NEWS
Earlier reports of ours on the same people and subjects.
- FDA approves new drug daraxonrasib for advanced pancreatic cancerMedical Breakthroughs, 28d ago
- Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk in Phase 3 TrialMedical Breakthroughs, 26d ago
- Seres Therapeutics reports Phase 1b trial results for SER-155 treatmentMedical Breakthroughs, 18d ago
- New genetic test helps identify aggressive prostate cancer to guide treatmentComebacks & Recovery, 28d ago
- Australian led trial shows mRNA vaccine lowers melanoma recurrence and deathMedical Breakthroughs, 29d ago
More in Medical Breakthroughs
- Arkansas scientists 3D print simulated Moon dust into interlocking building bricks16h ago
- GE HealthCare Foundation Grants Support Global Maternal and Pediatric Care16h ago
- Anthropic researcher uses artificial intelligence to prove Riemann hypothesis16h ago
- Texas Researchers Build Virtual Cell AI to Predict Disease and Treatments1d ago
- Florida Heart Institute Secures Medicare Approval for LVAD Heart Program1d ago
- Hyderabad doctor secures affordable rare disease medication for seven children2d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.


Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.